Purchases and Sales Made in Q3 2022 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q3 2022. The information is specifically focused on institutions that hold shares of ARROWHEAD PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 26, 2024
Q3 2022
|
Erste Asset Management Gmb H
Vienna, C4 |
SELL
|
- |
-13.8K- 29.36% |
$409K - $667K
|
33.2K
$864K
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-17.1K- 1.32% |
$506K - $825K
|
1.28M
$33.3M
|
|
Nov 10, 2022
Q3 2022
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-18K- 15.41% |
$533K - $870K
|
98.8K
$2.57M
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-18.2K- 52.04% |
$539K - $878K
|
16.8K
$436K
|
|
Nov 14, 2022
Q3 2022
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-18.8K- 62.15% |
$557K - $908K
|
11.4K
$298K
|
|
Nov 14, 2022
Q3 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-23.4K- 21.29% |
$692K - $1.13M
|
86.4K
$2.25M
|
|
Nov 03, 2022
Q3 2022
|
Fiera Capital Corp
Montreal, A8 |
SELL
|
- |
-24.4K- 2.18% |
$722K - $1.18M
|
1.09M
$28.5M
|
|
Nov 03, 2022
Q3 2022
|
Act Capital Management, LLC
Wayne, PA |
SELL
|
- |
-24.5K- 18.15% |
$726K - $1.18M
|
111K
$2.88M
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-29.2K- 61.73% |
$865K - $1.41M
|
18.1K
$471K
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-34.3K- 59.81% |
$1.02M - $1.66M
|
23.1K
$600K
|
|
Nov 10, 2022
Q3 2022
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-40K- 46.03% |
$1.18M - $1.93M
|
46.8K
$1.22M
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-42.6K- 54.04% |
$1.26M - $2.06M
|
36.2K
$942K
|
|
Nov 07, 2022
Q3 2022
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-50.7K- 10.03% |
$1.5M - $2.45M
|
455K
$11.8M
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-58.5K- 42.62% |
$1.73M - $2.82M
|
78.7K
$2.05M
|
|
Oct 31, 2022
Q3 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-76.2K- 64.57% |
$2.26M - $3.68M
|
41.8K
$1.09M
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-98.3K- 3.29% |
$2.91M - $4.75M
|
2.89M
$75.3M
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-112K- 20.7% |
$3.31M - $5.39M
|
427K
$11.1M
|
|
Nov 14, 2022
Q3 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-113K- 33.76% |
$3.35M - $5.45M
|
222K
$5.77M
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-120K- 19.8% |
$3.56M - $5.81M
|
487K
$12.7M
|
|
Nov 14, 2022
Q3 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-129K- 94.7% |
$3.82M - $6.24M
|
7.22K
$188K
|
|
Nov 14, 2022
Q3 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-156K- 77.82% |
$4.63M - $7.54M
|
44.5K
$1.16M
|
|
Nov 14, 2022
Q3 2022
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-184K- 12.76% |
$5.44M - $8.87M
|
1.26M
$32.7M
|
|
Nov 14, 2022
Q3 2022
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-186K- 70.66% |
$5.51M - $8.98M
|
77.2K
$2.01M
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-196K- 1.6% |
$5.82M - $9.49M
|
12.1M
$315M
|
|
Nov 15, 2022
Q3 2022
|
Nomura Holdings Inc
Tokyo, M0 |
SELL
|
- |
-197K- 92.62% |
$5.84M - $9.53M
|
15.7K
$409K
|
|
Nov 14, 2022
Q3 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-224K- 31.97% |
$6.63M - $10.8M
|
476K
$12.4M
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-328K- 5.88% |
$9.73M - $15.9M
|
5.25M
$137M
|
|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-331K- 11.83% |
$9.81M - $16M
|
2.47M
$64.2M
|
|
Apr 05, 2024
Q3 2022
|
E. Ohman J:Or Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-340K- 52.96% |
$10.1M - $16.4M
|
302K
$7.86M
|
|
Nov 10, 2022
Q3 2022
|
Johnson & Johnson
New Brunswick, NJ |
SELL
|
- |
-1.01M- 80.36% |
$30M - $49M
|
248K
$6.44M
|